OPKO Health Reports 2020 Third Quarter Business Highlights and Financial Results

NEXT STORY
Equillium Receives FDA Clearance of COVID-19 IND for Phase 3 Trial
PREV STORY
Agios to Host a Webinar on its Pyruvate Kinase-R (PKR) Activation Clinical Programs and Commercial Outlook on Thursday, November 19, 2020
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Chi-Med Announces that Surufatinib Phase III SANET-ep Study Has Met its Primary Endpoint at Interim Analysis in Advanced Non-Pancreatic Neuroendocrine Tumors in China and Will Stop Early

author_avatar
NASDAQ Market News

Immunocore announces dosing of first patient with fourth ImmTAC®

author_avatar
NASDAQ Market News

Arbutus Appoints William Collier as Next President & CEO and Announces Retirement of Current President & CEO, Mark J. Murray Ph.D.

author_avatar
NASDAQ Market News